Change Language

Select Language

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

Antihypertensive Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

Market Overview:

The global antihypertensive drugs market exhibited XX growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of XX% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different XX. These insights are included in the report as a major market contributor.

Antihypertensive drugs are therapeutic medications used for preventing, controlling and treating hypertension and high blood pressure disorders. Hypertension is the prolonged and persistent elevation in blood pressure, which can lead to cardiac stroke and aneurism. Some commonly used antihypertensive drugs include diuretics, beta-blockers, calcium channel blockers, angiotensin-converting enzyme (ACE) inhibitors and vasodilators. These drugs remove excess fluids and salts from the body and relax and widen the blood vessels. They also aid in slowing down the heartbeat and maintaining a healthy systolic blood pressure. These drugs can be administered orally or through intravenous injections and are widely used in hospitals, clinics, rehabilitation centers and ambulatory surgical centers.

 

 
 

www.imarcgroup.com

Note: Values and trends in the above chart consists of dummy data and are only shown here for representation purpose. Kindly contact us for the actual market size and trends.

To get more information about this market, Request Sample

Antihypertensive Drugs Market Trends:

The increasing prevalence of hypertension and cardiovascular disorders across the globe is one of the key factors driving the growth of the market. Moreover, the rising geriatric population, which is more susceptible to such ailments, is anticipated to drive the market toward growth. Due to the increasingly sedentary lifestyles and adoption of unhealthy dietary patterns, there is an alarming increase in the number of patients suffering from high blood pressure and hypertension. This has led to the widespread adoption of antihypertensive drugs for timely prevention and treatment of hypertension. In line with this, the widespread adoption of combination therapies is contributing to the growth of the market. These innovative therapies combine multiple drugs to treat several hypertensive mechanisms, resulting in reduced occurrence of cerebrovascular events and coronary issues. Additionally, the development of imidazolines, monatepil and neutral endopeptidase inhibitors are acting as other growth-inducing factors. These next-generation drugs cause minimal fatigue and dry mouth and can also aid in lowering blood pressure by inhibiting the metabolism of vasoactive peptides. Other factors, including rising healthcare expenditures of the consumers, along with extensive research and development (R&D) activities, are anticipated to drive the market toward growth. 

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global antihypertensive drugs market report, along with forecasts for growth at the global, regional and country level from 2021-2026. Our report has categorized the market based on therapeutic class, type and distribution channel.

Breakup by Therapeutic Class:

 

 
 

www.imarcgroup.com

Note: Values and trends in the above chart consists of dummy data and are only shown here for representation purpose. Kindly contact us for the actual market size and trends.

To get more information about this market, Request Sample

  • Diuretics
  • ACE Inhibitors
  • Calcium Channel Blockers
  • Beta-adrenergic Blockers
  • Vasodilators
  • Others
     

Breakup by Type:

  • Primary hypertension
  • Secondary Hypertension
     

Breakup by Distribution Channel:

  • Retail Pharmacy
  • Hospital Pharmacy
  • E-Commerce
     

Breakup by Region:

 

 
 

www.imarcgroup.com

To get more information on the regional analysis of this market, Request Sample

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being AstraZeneca, Boehringer Ingelheim International GmbH., Daiichi Sankyo Company Limited, Johnson & Johnson Services Inc., Lupin Pharmaceuticals Inc, Merck & Co. Inc., Novartis AG, Pfizer Inc., Sanofi and Sun Pharmaceutical Industries Ltd.

Report Coverages:

Report Features Details
Base Year of the Analysis 2020
    Historical Period 2015-2020
Forecast Period 2021-2026
Units US$ Billion
Segment Coverage Therapeutic Class, Type, Distribution Channel, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered AstraZeneca, Boehringer Ingelheim International GmbH., Daiichi Sankyo Company Limited, Johnson & Johnson Services Inc., Lupin Pharmaceuticals Inc, Merck & Co. Inc., Novartis AG, Pfizer Inc., Sanofi and Sun Pharmaceutical Industries Ltd.
Customization Scope 10% Free Customization
Report Price and Purchase Option                                     Single User License: US$ 2299
Five User License: US$ 3399
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

Key Questions Answered in This Report:

  • How has the global antihypertensive drugs market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global antihypertensive drugs market?
  • What are the key regional markets?
  • What is the breakup of the market based on the therapeutic class?
  • What is the breakup of the market based on the type?
  • What is the breakup of the market based on the distribution channel?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global antihypertensive drugs market and who are the key players?
  • What is the degree of competition in the industry?

1    Preface
2    Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Introduction

    4.1    Overview
    4.2    Key Industry Trends
5    Global Antihypertensive Drugs Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6    Market Breakup by Therapeutic Class
    6.1    Diuretics
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    ACE Inhibitors
        6.2.1 Market Trends
        6.2.2 Market Forecast
    6.3    Calcium Channel Blockers
        6.3.1 Market Trends
        6.3.2 Market Forecast
    6.4    Beta-adrenergic Blockers
        6.4.1 Market Trends
        6.4.2 Market Forecast
    6.5    Vasodilators
        6.5.1 Market Trends
        6.5.2 Market Forecast
    6.6    Others
        6.6.1 Market Trends
        6.6.2 Market Forecast
7    Market Breakup by Type
    7.1    Primary hypertension
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Secondary Hypertension
        7.2.1 Market Trends
        7.2.2 Market Forecast
8    Market Breakup by Distribution Channel
    8.1    Retail Pharmacy
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Hospital Pharmacy
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    E-commerce
        8.3.1 Market Trends
        8.3.2 Market Forecast
9    Market Breakup by Region
    9.1    North America
        9.1.1 United States
           9.1.1.1 Market Trends
           9.1.1.2 Market Forecast
        9.1.2 Canada
           9.1.2.1 Market Trends
           9.1.2.2 Market Forecast
    9.2    Asia-Pacific
        9.2.1 China
           9.2.1.1 Market Trends
           9.2.1.2 Market Forecast
        9.2.2 Japan
           9.2.2.1 Market Trends
           9.2.2.2 Market Forecast
        9.2.3 India
           9.2.3.1 Market Trends
           9.2.3.2 Market Forecast
        9.2.4 South Korea
           9.2.4.1 Market Trends
           9.2.4.2 Market Forecast
        9.2.5 Australia
           9.2.5.1 Market Trends
           9.2.5.2 Market Forecast
        9.2.6 Indonesia
           9.2.6.1 Market Trends
           9.2.6.2 Market Forecast
        9.2.7 Others
           9.2.7.1 Market Trends
           9.2.7.2 Market Forecast
    9.3    Europe
        9.3.1 Germany
           9.3.1.1 Market Trends
           9.3.1.2 Market Forecast
        9.3.2 France
           9.3.2.1 Market Trends
           9.3.2.2 Market Forecast
        9.3.3 United Kingdom
           9.3.3.1 Market Trends
           9.3.3.2 Market Forecast
        9.3.4 Italy
           9.3.4.1 Market Trends
           9.3.4.2 Market Forecast
        9.3.5 Spain
           9.3.5.1 Market Trends
           9.3.5.2 Market Forecast
        9.3.6 Russia
           9.3.6.1 Market Trends
           9.3.6.2 Market Forecast
        9.3.7 Others
           9.3.7.1 Market Trends
           9.3.7.2 Market Forecast
    9.4    Latin America
        9.4.1 Brazil
           9.4.1.1 Market Trends
           9.4.1.2 Market Forecast
        9.4.2 Mexico
           9.4.2.1 Market Trends
           9.4.2.2 Market Forecast
        9.4.3 Others
           9.4.3.1 Market Trends
           9.4.3.2 Market Forecast
    9.5    Middle East and Africa
        9.5.1 Market Trends
        9.5.2 Market Breakup by Country
        9.5.3 Market Forecast
10    SWOT Analysis
    10.1    Overview
    10.2    Strengths
    10.3    Weaknesses
    10.4    Opportunities
    10.5    Threats
11    Value Chain Analysis
12    Porters Five Forces Analysis

    12.1    Overview
    12.2    Bargaining Power of Buyers
    12.3    Bargaining Power of Suppliers
    12.4    Degree of Competition
    12.5    Threat of New Entrants
    12.6    Threat of Substitutes
13    Price Analysis
14    Competitive Landscape

    14.1    Market Structure
    14.2    Key Players
    14.3    Profiles of Key Players
        14.3.1    AstraZeneca
           14.3.1.1 Company Overview
           14.3.1.2 Product Portfolio
           14.3.1.3 Financials
           14.3.1.4 SWOT Analysis
        14.3.2    Boehringer Ingelheim International GmbH.
           14.3.2.1 Company Overview
           14.3.2.2 Product Portfolio
        14.3.3    Daiichi Sankyo Company Limited
           14.3.3.1 Company Overview
           14.3.3.2 Product Portfolio
           14.3.3.3 Financials
           14.3.3.4 SWOT Analysis
        14.3.4    Johnson & Johnson Services Inc.
           14.3.4.1 Company Overview
           14.3.4.2 Product Portfolio
           14.3.4.3 Financials
           14.3.4.4 SWOT Analysis
        14.3.5    Lupin Pharmaceuticals Inc
           14.3.5.1 Company Overview
           14.3.5.2 Product Portfolio
        14.3.6    Merck & Co. Inc.
           14.3.6.1 Company Overview
           14.3.6.2 Product Portfolio
           14.3.6.3 Financials
           14.3.6.4 SWOT Analysis
        14.3.7    Novartis AG
           14.3.7.1 Company Overview
           14.3.7.2 Product Portfolio
           14.3.7.3 Financials
           14.3.7.4 SWOT Analysis
        14.3.8    Pfizer Inc.
           14.3.8.1 Company Overview
           14.3.8.2 Product Portfolio
           14.3.8.3 Financials
           14.3.8.4 SWOT Analysis
        14.3.9    Sanofi
           14.3.9.1 Company Overview
           14.3.9.2 Product Portfolio
           14.3.9.3 Financials
           14.3.9.4 SWOT Analysis
        14.3.10    Sun Pharmaceutical Industries Ltd. 
           14.3.10.1 Company Overview
           14.3.10.2 Product Portfolio
           14.3.10.3 Financials
           14.3.10.4 SWOT Analysis

List of Figures

Figure 1: Global: Antihypertensive Drugs Market: Major Drivers and Challenges
Figure 2: Global: Antihypertensive Drugs Market: Sales Value (in Billion US$), 2015-2020
Figure 3: Global: Antihypertensive Drugs Market Forecast: Sales Value (in Billion US$), 2021-2026
Figure 4: Global: Antihypertensive Drugs Market: Breakup by Therapeutic Class (in %), 2020
Figure 5: Global: Antihypertensive Drugs Market: Breakup by Type (in %), 2020
Figure 6: Global: Antihypertensive Drugs Market: Breakup by Distribution Channel (in %), 2020
Figure 7: Global: Antihypertensive Drugs Market: Breakup by Region (in %), 2020
Figure 8: Global: Antihypertensive Drugs (Diuretics) Market: Sales Value (in Million US$), 2015 & 2020
Figure 9: Global: Antihypertensive Drugs (Diuretics) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 10: Global: Antihypertensive Drugs (ACE Inhibitors) Market: Sales Value (in Million US$), 2015 & 2020
Figure 11: Global: Antihypertensive Drugs (ACE Inhibitors) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 12: Global: Antihypertensive Drugs (Calcium Channel Blockers) Market: Sales Value (in Million US$), 2015 & 2020
Figure 13: Global: Antihypertensive Drugs (Calcium Channel Blockers) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 14: Global: Antihypertensive Drugs (Beta-adrenergic Blockers) Market: Sales Value (in Million US$), 2015 & 2020
Figure 15: Global: Antihypertensive Drugs (Beta-adrenergic Blockers) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 16: Global: Antihypertensive Drugs (Vasodilators) Market: Sales Value (in Million US$), 2015 & 2020
Figure 17: Global: Antihypertensive Drugs (Vasodilators) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 18: Global: Antihypertensive Drugs (Other Therapeutic Classes) Market: Sales Value (in Million US$), 2015 & 2020
Figure 19: Global: Antihypertensive Drugs (Other Therapeutic Classes) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 20: Global: Antihypertensive Drugs (Primary hypertension) Market: Sales Value (in Million US$), 2015 & 2020
Figure 21: Global: Antihypertensive Drugs (Primary hypertension) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 22: Global: Antihypertensive Drugs (Secondary Hypertension) Market: Sales Value (in Million US$), 2015 & 2020
Figure 23: Global: Antihypertensive Drugs (Secondary Hypertension) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 24: Global: Antihypertensive Drugs (Retail Pharmacy) Market: Sales Value (in Million US$), 2015 & 2020
Figure 25: Global: Antihypertensive Drugs (Retail Pharmacy) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 26: Global: Antihypertensive Drugs (Hospital Pharmacy) Market: Sales Value (in Million US$), 2015 & 2020
Figure 27: Global: Antihypertensive Drugs (Hospital Pharmacy) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 28: Global: Antihypertensive Drugs (E-Commerce) Market: Sales Value (in Million US$), 2015 & 2020
Figure 29: Global: Antihypertensive Drugs (E-Commerce) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 30: North America: Antihypertensive Drugs Market: Sales Value (in Million US$), 2015 & 2020
Figure 31: North America: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 32: United States: Antihypertensive Drugs Market: Sales Value (in Million US$), 2015 & 2020
Figure 33: United States: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 34: Canada: Antihypertensive Drugs Market: Sales Value (in Million US$), 2015 & 2020
Figure 35: Canada: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 36: Asia-Pacific: Antihypertensive Drugs Market: Sales Value (in Million US$), 2015 & 2020
Figure 37: Asia-Pacific: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 38: China: Antihypertensive Drugs Market: Sales Value (in Million US$), 2015 & 2020
Figure 39: China: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 40: Japan: Antihypertensive Drugs Market: Sales Value (in Million US$), 2015 & 2020
Figure 41: Japan: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 42: India: Antihypertensive Drugs Market: Sales Value (in Million US$), 2015 & 2020
Figure 43: India: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 44: South Korea: Antihypertensive Drugs Market: Sales Value (in Million US$), 2015 & 2020
Figure 45: South Korea: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 46: Australia: Antihypertensive Drugs Market: Sales Value (in Million US$), 2015 & 2020
Figure 47: Australia: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 48: Indonesia: Antihypertensive Drugs Market: Sales Value (in Million US$), 2015 & 2020
Figure 49: Indonesia: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 50: Others: Antihypertensive Drugs Market: Sales Value (in Million US$), 2015 & 2020
Figure 51: Others: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 52: Europe: Antihypertensive Drugs Market: Sales Value (in Million US$), 2015 & 2020
Figure 53: Europe: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 54: Germany: Antihypertensive Drugs Market: Sales Value (in Million US$), 2015 & 2020
Figure 55: Germany: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 56: France: Antihypertensive Drugs Market: Sales Value (in Million US$), 2015 & 2020
Figure 57: France: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 58: United Kingdom: Antihypertensive Drugs Market: Sales Value (in Million US$), 2015 & 2020
Figure 59: United Kingdom: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 60: Italy: Antihypertensive Drugs Market: Sales Value (in Million US$), 2015 & 2020
Figure 61: Italy: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 62: Spain: Antihypertensive Drugs Market: Sales Value (in Million US$), 2015 & 2020
Figure 63: Spain: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 64: Russia: Antihypertensive Drugs Market: Sales Value (in Million US$), 2015 & 2020
Figure 65: Russia: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 66: Others: Antihypertensive Drugs Market: Sales Value (in Million US$), 2015 & 2020
Figure 67: Others: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 68: Latin America: Antihypertensive Drugs Market: Sales Value (in Million US$), 2015 & 2020
Figure 69: Latin America: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 70: Brazil: Antihypertensive Drugs Market: Sales Value (in Million US$), 2015 & 2020
Figure 71: Brazil: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 72: Mexico: Antihypertensive Drugs Market: Sales Value (in Million US$), 2015 & 2020
Figure 73: Mexico: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 74: Others: Antihypertensive Drugs Market: Sales Value (in Million US$), 2015 & 2020
Figure 75: Others: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 76: Middle East and Africa: Antihypertensive Drugs Market: Sales Value (in Million US$), 2015 & 2020
Figure 77: Middle East and Africa: Antihypertensive Drugs Market: Breakup by Country (in %), 2020
Figure 78: Middle East and Africa: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 79: Global: Antihypertensive Drugs Industry: SWOT Analysis
Figure 80: Global: Antihypertensive Drugs Industry: Value Chain Analysis
Figure 81: Global: Antihypertensive Drugs Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Antihypertensive Drugs Market: Key Industry Highlights, 2020 and 2026
Table 2: Global: Antihypertensive Drugs Market Forecast: Breakup by Therapeutic Class (in Million US$), 2021-2026
Table 3: Global: Antihypertensive Drugs Market Forecast: Breakup by Type (in Million US$), 2021-2026
Table 4: Global: Antihypertensive Drugs Market Forecast: Breakup by Distribution Channel (in Million US$), 2021-2026
Table 5: Global: Antihypertensive Drugs Market Forecast: Breakup by Region (in Million US$), 2021-2026
Table 6: Global: Antihypertensive Drugs Market: Competitive Structure
Table 7: Global: Antihypertensive Drugs Market: Key Players

Note: We value your privacy and will never rent or sell your email address. Privacy policy

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Purchase Options




$ 2299

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )


Drop us an email at

sales@imarcgroup.com

Social Links